These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2605804)

  • 1. Culture of fungi on cyanoacrylate skin surface strippings--a quantitative bioassay for evaluating antifungal drugs.
    Rurangirwa A; Piérard-Franchimont C; Piérard GE
    Clin Exp Dermatol; 1989 Nov; 14(6):425-8. PubMed ID: 2605804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of the triazole antifungal r126638 as assessed by corneofungimetry.
    Piérard-Franchimont C; Ausma J; Wouters L; Vroome V; Vandeplassche L; Borgers M; Cauwenbergh G; Piérard GE
    Skin Pharmacol Physiol; 2006; 19(1):50-6. PubMed ID: 16247249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the activity and lingering effect of topical antifungals.
    Piérard GE; Piérard-Franchimont C; Estrada JA
    Skin Pharmacol; 1993; 6(3):208-14. PubMed ID: 8274291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methods for demonstration of fungistatic and fungicide activity in vitro].
    Carlone N; Scannerini S
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(1):59-88. PubMed ID: 4647717
    [No Abstract]   [Full Text] [Related]  

  • 5. Laboratory tests of antifungal drugs.
    Holt RJ
    J Clin Pathol; 1975 Oct; 28(10):767-74. PubMed ID: 765359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new bioassay model of antibiotic susceptibility by corneofungimetry].
    Zhao JY; Xu W; Wang L; Jiang DL; Li YZ
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(5):332-5. PubMed ID: 16677528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungal cultures on cyanoacrylate skin surface strippings as a dose-finding method for topical antifungals. A placebo-controlled study with 0.25% and 0.50% itraconazole cream.
    Arrese JE; Schrooten P; de Doncker P; de Smett H; Cauwenbergh G; Piérard-Franchimont C; Piérard GE
    J Med Vet Mycol; 1995; 33(2):127-30. PubMed ID: 7658304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of ornithophillic fungi to some drugs.
    Patel A; Agrawal SC
    Hindustan Antibiot Bull; 2002; 44(1-4):49-52. PubMed ID: 15061595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updating corneofungimetry: a bioassay exploring dermatomycoses and antifungal susceptibility.
    Piérard GE; Piérard-Franchimont C; Quatresooz P
    Mycopathologia; 2010 Jan; 169(1):27-35. PubMed ID: 19644764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory tests of antifungal drugs in treatment of systemic mycoses.
    Holmberg K
    Scand J Infect Dis Suppl; 1978; (16):65-73. PubMed ID: 373080
    [No Abstract]   [Full Text] [Related]  

  • 11. Susceptibility testing of terbinafine alone and in combination with amphotericin B, itraconazole, or voriconazole against conidia and hyphae of dematiaceous molds.
    Biancalana FS; Lyra L; Moretti ML; Schreiber AZ
    Diagn Microbiol Infect Dis; 2011 Dec; 71(4):378-85. PubMed ID: 21945391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity and post antifungal effect of chlorpromazine and trifluopherazine against Aspergillus, Scedosporium and zygomycetes.
    Vitale RG; Afeltra J; Meis JF; Verweij PE
    Mycoses; 2007 Jul; 50(4):270-6. PubMed ID: 17576318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products.
    Gligorijevic V; Benel C; Gonzalez P; Saint-Pol A
    J Vis Exp; 2020 Dec; (166):. PubMed ID: 33346196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility testing in fungi: a global perspective on a variety of methods.
    Lass-Flörl C; Perkhofer S; Mayr A
    Mycoses; 2010 Jan; 53(1):1-11. PubMed ID: 20078786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds.
    Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing
    Clin Microbiol Infect; 2008 Oct; 14(10):982-4. PubMed ID: 18828858
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction in the growth of non-dermatophyte moulds by itraconazole: evaluation by corneofungimetry assay.
    Arrese JE; De Doncker P; Odds FC; Piérard GE
    Mycoses; 1998 Dec; 41(11-12):461-5. PubMed ID: 9919887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple fluorescence-based high throughput cell viability assay for filamentous fungi.
    Chadha S; Kale SP
    Lett Appl Microbiol; 2015 Sep; 61(3):238-44. PubMed ID: 26118969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cladosporin, a new antifungal metabolite from Cladosporium cladosporioides.
    Scott PM; Van Walbeek W; MacLean WM
    J Antibiot (Tokyo); 1971 Nov; 24(11):747-55. PubMed ID: 5169000
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro antifungal susceptibility methods and clinical implications of antifungal resistance.
    Espinel-Ingroff A; Warnock DW; Vazquez JA; Arthington-Skaggs BA
    Med Mycol; 2000; 38 Suppl 1():293-304. PubMed ID: 11204157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Searching new antifungals: The use of in vitro and in vivo methods for evaluation of natural compounds.
    Scorzoni L; Sangalli-Leite F; de Lacorte Singulani J; de Paula E Silva AC; Costa-Orlandi CB; Fusco-Almeida AM; Mendes-Giannini MJ
    J Microbiol Methods; 2016 Apr; 123():68-78. PubMed ID: 26853122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.